GSA Capital Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-20,819
| Closed | -$108K | – | 2109 |
|
|
2024
Q3 | $108K | Buy |
+20,819
| New | +$108K | 0.01% | 1481 |
|
|
2023
Q1 | – | Sell |
-45,659
| Closed | -$843K | – | 2005 |
|
|
2022
Q4 | $843K | Buy |
+45,659
| New | +$843K | 0.1% | 289 |
|
|
2022
Q3 | – | Sell |
-42,978
| Closed | -$594K | – | 1937 |
|
|
2022
Q2 | $594K | Sell |
42,978
-24,254
| -36% | -$335K | 0.09% | 389 |
|
|
2022
Q1 | $1.31M | Buy |
+67,232
| New | +$1.31M | 0.18% | 97 |
|
|
2021
Q3 | – | Sell |
-24,498
| Closed | -$726K | – | 1845 |
|
|
2021
Q2 | $726K | Buy |
+24,498
| New | +$726K | 0.08% | 392 |
|
|
2020
Q2 | – | Sell |
-30,574
| Closed | -$452K | – | 1197 |
|
|
2020
Q1 | $452K | Buy |
+30,574
| New | +$452K | 0.11% | 219 |
|
|
2019
Q1 | – | Sell |
-10,451
| Closed | -$210K | – | 1739 |
|
|
2018
Q4 | $210K | Buy |
+10,451
| New | +$210K | 0.02% | 1077 |
|
|
2018
Q3 | – | Sell |
-14,800
| Closed | -$406K | – | 1961 |
|
|
2018
Q2 | $406K | Buy |
+14,800
| New | +$406K | 0.02% | 1253 |
|